Ss innovations announces filing of pre-submission application to the center for devices and radiological health (cdrh) of the united states food and drug administration

Fort lauderdale, fla., jan. 26, 2024 (globe newswire) -- ss innovations international, inc. (the “company” or “ss innovations”) (otc: ssii), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that it has filed a pre-submission application with the u.s. food and drug administration (fda) requesting feedback on its ssi mantra™ surgical robotic system.
SSII Ratings Summary
SSII Quant Ranking